【产品介绍】：

生物活性：L-Lysine6-13C (dihydrochloride) is a 13C-labeled L-Lysine dihydrochloride.
体外研究(In Vitro)：Stable heavy isotopes of hydrogen, carbon, and other elements have been incorporated into drug molecules, largely as tracers for quantitation during the drug development process. Deuteration has gained attention because of its potential to affect the pharmacokinetic and metabolic profiles of drugs[1].
德尔塔生物 has not independently confirmed the accuracy of these methods. They are for reference only.
L-Lysine6-13C dihydrochloride 相关抗体:
PD-L1 Antibody
PDCD4 Antibody
MRP2 Antibody
Elongation factor 2 Antibody (YA962)
Elongation factor 2 Antibody (YA964)
PU.1/SPI1 Antibody (YA1116)
PD-L2 Antibody (YA1584)
Sulfadimidine Antibody (YA906)
Elongation factor 2 Antibody (YA963)
Anthrax Protective gen Antibody (YA1060)
PDCD6/ALG-2 Antibody (YA1265)
VISTA Antibody (YA1276)
PDCD2 Antibody (YA1312)
PD-L2 Antibody (YA1348)
Elongation factor 1 gamma Antibody (YA2004)
Pulmonary Surfactant Associated Protein D Antibody (YA2107)
TPP1 Antibody (YA2244)
Cathelicidin Antibody (YA2380)
Elongation Factor Ts Antibody (YA2524)
Elongation Factor 1A2 Antibody (YA2879)
BPI Antibody (YA3068)
MetRS Antibody (YA3196)
分子量：220.10
Formula：C513CH16Cl2N2O2
CAS 号：1217466-44-8
非标记 CAS：657-26-1
中文名称：L-赖氨酸-6-13C 二双盐酸盐
运输条件：Room temperature in continental US; may vary elsewhere.
储存方式：Please store the product under the recommended conditions in the Certificate of Analysis.
纯度 & 产品资料
Data Sheet (515 KB)
产品使用指南 (1538 KB)
参考文献
[1]. Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019 Feb;53(2):211-216.
 [Content Brief]